APO RIS 35 (Risedronate Sodium 35 mg)
Pill with imprint APO RIS 35 is Orange, Round and has been identified as Risedronate Sodium 35 mg. It is supplied by Apotex Corp.
Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO RIS 35
Risedronate Sodium
- Imprint
- APO RIS 35
- Strength
- 35 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- National Drug Code (NDC)
- 60505-3165
- Inactive Ingredients
-
ferric oxide red,
ferric oxide yellow,
hydroxypropyl cellulose,
hypromelloses,
magnesium stearate,
polyethylene glycol 8000,
titanium dioxide,
lactose anhydrous,
silicon dioxide
Note: Inactive ingredients may vary.
More about risedronate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (66)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: bisphosphonates
Patient resources
- Drug Information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.